Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patients

Affiliations

• ¹ Médecins sans Frontières, Public Health Department, Amsterdam, The Netherlands. bern.nyangwa@london.msf.org.
• ² Institute for Global Health, University College London, London, UK. bern.nyangwa@london.msf.org.
• ³ University College London, MRC-CTU, London, UK.
• ⁴ THINK (TB and HIV Investigative Network, Durban, South Africa.
• ⁵ Republican Scientific and Practical Centre of Pulmonology and Tuberculosis, Minsk, Belarus.
• ⁶ Clinical HIV Research Unit (CHRU), Department of Internal Medicine, School of Clinical medicine, Faculty of Health Sciences, Wits Health Consortium (WHC), University of Witwatersrand, Johannesburg, South Africa.
• ⁷ Manson Unit, Public Health Department, Médecins sans Frontières, London, UK.
• ⁸ UCL-GOSH Institute of Child Health, University College London, London, UK.
• ⁹ Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, UK.
• ¹⁰ London School of Hygiene and Tropical Medicine, Clinical Research Department, London, UK.
• ¹¹ Institute for Global Health, University College London, London, UK. f.kloprogge@ucl.ac.uk.